Low-dose heparin: is the risk worth the benefit?
D000208:Acute Disease; D001777:Blood Coagulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D045166:Estradiol Congeners / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007103:Immobilization; D007279:Injections, Subcutaneous; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D012131:Respiratory Insufficiency / Q000150:complications; D012306:Risk; D013924:Thrombophlebitis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*
D045166:Estradiol Congeners; D006493:Heparin